Physiomics plc (AIM: PYC): New contract by Numab TherapeuticsPoolbeg Pharma plc (AIM: POLB): Peer-reviewed POLB 001 LPS challenge trial paper publicationSolvonis Therapeutics plc (LSE: SVNS): Expansion of SVN-015 into depression following positive preclinical data
28 Jan 2026
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
SP Angel Healthcare Conditions
Solvonis Therapeutics Plc (SVNS:LON), 0.3 | Poolbeg Pharma PLC (POLB:LON), 4.4 | Physiomics Plc (PYC:LON), 0.3
- Published:
28 Jan 2026 -
Author:
Vadim Alexandre | Greg Pave -
Pages:
4 -
Physiomics plc (AIM: PYC): New contract by Numab TherapeuticsPoolbeg Pharma plc (AIM: POLB): Peer-reviewed POLB 001 LPS challenge trial paper publicationSolvonis Therapeutics plc (LSE: SVNS): Expansion of SVN-015 into depression following positive preclinical data